Clinical Trial Update: Calcium Aspirin Multiple Micronutrients (CAMMS) to Reduce Preterm Birth [Phase 3]

View source ↗

Summary

Phase 3 trial CAMMS for reducing preterm birth was withdrawn. The study covered preterm labor and fetal growth/neonatal outcomes but is not proceeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertensive Disorder of Pregnancy
• Low Birth Weight
• Neonatal Death
• Preterm Labor
• Small For Gestational Age At Delivery

Drugs mentioned

• Calcium Aspirin Multiple Micronutrients (CAMMS)

Snippet

Sponsor: Johns Hopkins Bloomberg School of Public Health | Conditions: Preterm Labor, Small for Gestational Age at Delivery | Phase 3 | Status: WITHDRAWN